Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Geoffrey Ira Shapiro, M.D., Ph.D.

Concepts (627)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Geoffrey Shapiro's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Geoffrey Shapiro has written about over time.
Cyclin-Dependent Kinases, 14 publications between 1995 and 2024, average publication date May 2008. Carcinoma, Non-Small-Cell Lung, 48 publications between 1995 and 2023, average publication date January 2010. Piperidines, 15 publications between 1999 and 2020, average publication date March 2010. Cyclin-Dependent Kinase 4, 12 publications between 1995 and 2024, average publication date May 2012. HSP90 Heat-Shock Proteins, 14 publications between 2005 and 2021, average publication date February 2013. Cyclin-Dependent Kinase 6, 9 publications between 1995 and 2019, average publication date March 2013. Antineoplastic Agents, 71 publications between 1999 and 2023, average publication date August 2013. Sulfonamides, 11 publications between 2004 and 2024, average publication date March 2014. Maximum Tolerated Dose, 31 publications between 2008 and 2021, average publication date July 2014. Neoplasms, 69 publications between 1995 and 2024, average publication date October 2014. Protein Kinase Inhibitors, 50 publications between 1995 and 2024, average publication date February 2015. Antineoplastic Combined Chemotherapy Protocols, 43 publications between 2002 and 2024, average publication date November 2015. Pyrazoles, 19 publications between 2010 and 2021, average publication date December 2015. Piperazines, 12 publications between 2006 and 2024, average publication date January 2017. Benzimidazoles, 6 publications between 2011 and 2021, average publication date March 2017. BRCA1 Protein, 10 publications between 2009 and 2024, average publication date April 2017. Ovarian Neoplasms, 18 publications between 2013 and 2024, average publication date March 2020. Cystadenocarcinoma, Serous, 5 publications between 2018 and 2021, average publication date April 2020. Pyrazines, 12 publications between 2015 and 2024, average publication date August 2020.

To see the data from this visualization as text, click here.
Shapiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (627)
Explore
_
Co-Authors (269)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.